Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc. to December 16, 2019

    NEXT STORY
    Genomics Market to Exhibit a Stellar CAGR of 18.7%, Demand for Genomic Products to Augment Owing to Increasing Number of Product Launches: Fortune Business Insights
    PREV STORY
    Changes in the Board of Directors and the Corporate Executive Committee of Roche
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Kura Oncology to Report Second Quarter 2019 Financial Results

    author_avatar
    NASDAQ Market News

    Helix Biopharma Corp. Announces Fiscal Third Quarter 2020 Results

    author_avatar
    NASDAQ Market News

    Novartis announces Kymriah® meets primary endpoint at interim analysis of pivotal study in follicular lymphoma

    author_avatar
    NASDAQ Market News